1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 12 (Search time: 0.001 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALDI-TOF mass spectrometry: Reliable genotyping in different ethnic groupsSchaeffeler, E.; Zanger, U.; Eichelbaum, M.; Asante-Poku, S.; Shin, J.; Schwab, M.
2007Effects of rifampicin on global gene expression in human small intestineOscarson, M.; Burk, O.; Winter, S.; Schwab, M.; Wolbold, R.; Dippon, J.; Eichelbaum, M.; Meyer, U.
2007Predictive value of known and novel alleles ofCYP2B6 for efavirenz plasma concentrations in HIV-infected individualsRotger, M.; Tegude, H.; Colombo, S.; Cavassini, M.; Furrer, H.; Decosterd, L.; Blievernicht, J.; Saussele, T.; Gunthard, H.; Schwab, M.; Eichelbaum, M.; Telenti, A.; Zanger, U.
2009Genetic influences on the pharmacokinetics of orally and intravenously administered Digoxin as exhibited by monozygotic twinsBirkenfeld, A.; Jordan, J.; Hofmann, U.; Busjahn, A.; Franke, G.; Kruger, N.; Igel, S.; Murdter, T.; Drescher, S.; Shi, S.; Engeli, S.; Schwab, M.; Eichelbaum, M.; Luft, F.; Fromm, M.
2007Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizoleSaussele, T.; Burk, O.; Blievernicht, J.; Nussler, A.; Nussler, N.; Hengstler, J.; Eichelbaum, M.; Schwab, M.; Zanger, U.
2008Variability in human hepatic MRP4 expression: Influence of cholestasis and genotypeGradhand, U.; Lang, T.; Schaeffeler, E.; Glaeser, H.; Tegude, H.; Klein, K.; Fritz, P.; Jedlitschky, G.; Kroemer, H.; Bachmakov, I.; Anwald, B.; Kerb, R.; Zanger, U.; Eichelbaum, M.; Schwab, M.; Fromm, M.
2007Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypesSchroth, W.; Antoniadou, L.; Fritz, P.; Schwab, M.; Muerdter, T.; Zanger, U.; Simon, W.; Eichelbaum, M.; Brauch, H.
2009Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocolsStanulla, M.; Schaeffeler, E.; Moricke, A.; Coulthard, S.; Cario, G.; Schrauder, A.; Kaatsch, P.; Dordelmann, M.; Welte, K.; Zimmerman, M.; Reiter, A.; Eichelbaum, M.; Riehm, H.; Schrappe, M.; Schwab, M.
2008Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study GroupSchwab, M.; Zanger, U.; Marx, C.; Schaeffeler, E.; Klein, K.; Dippon, J.; Kerb, R.; Blievernicht, J.; Fischer, J.; Hofmann, U.; Bokemeyer, C.; Eichelbaum, M.
2008A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancerRokavec, M.; Schroth, W.; Amaral, S.; Fritz, P.; Antoniadou, L.; Glavac, D.; Simon, W.; Schwab, M.; Eichelbaum, M.; Brauch, H.

Discover